NCT02277574 - Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

July 31, 2015

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

AMP-110

2, 5, or 10 mg/kg

OTHER

Placebo

Trial Locations (7)

Altoona Center for Clinical Research, Duncansville

Arthritis Treatment Center, Frederick

Omega Research Consultants, LLC., Orlando

Arthritis Center, Inc., Palm Harbor

Pinnacle Research Group, LLC, Anniston

Physician Research Collaboration, LLC, Lincoln

Metroplex Clinical Research Center, Dallas